Biotechnology
Bothell’s CMC Biologics expands facility to develop drugs for clinical trials
BOTHELL -- CMC Biologics unveiled a $10 million addition to the Bothell biotech company's cellular manufacturing plant on Wednesday.
Date: 09/23/2011 | Business




